Transient Global Ischemia in Rats Yields Striatal Projection Neuron and Interneuron Loss Resembling That in Huntington's Disease

Albin, 1992, Alternative excitotoxic hypotheses, Neurology, 42, 733, 10.1212/WNL.42.4.733 Albin, 1992, Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease, Ann. Neurol., 31, 425, 10.1002/ana.410310412 Albin, 1990, Striatal and nigral neuron subpopulations in rigid Huntington's disease: Implications for the functional anatomy of chorea and rigidity-akinesia, Ann. Neurol., 27, 357, 10.1002/ana.410270403 Albin, 1990, Abnormalities of striatal projection neurons and N-methyl-d-aspartate receptors in presymptomatic Huntington's disease, N. Engl. J. Med., 322, 1293, 10.1056/NEJM199005033221807 Anderson, 1990, Distribution and relative abundance of neurons in the pigeon forebrain containing somatostatin, neuropeptide Y, or both, J. Comp. Neurol., 299, 261, 10.1002/cne.902990302 Anderson, 1990, Extensive co-occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization, J. Comp. Neurol., 295, 339, 10.1002/cne.902950302 Arai, 1987, Huntington's disease: Changes in tachykinin content in postmortem brains, Ann. Neurol., 22, 587, 10.1002/ana.410220505 Beal, 1993, Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid, J. Neurosci., 13, 4181, 10.1523/JNEUROSCI.13-10-04181.1993 Beal, 1988, A detailed examination of substance P in pathologically graded cases of Huntington's disease, J. Neurol. Sci., 84, 51, 10.1016/0022-510X(88)90173-6 Beal, 1991, Chronic quinolinic acid lesions in rats closely resemble Huntington's disease, J. Neurosci., 11, 1649, 10.1523/JNEUROSCI.11-06-01649.1991 Beal, 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci., 16, 125, 10.1016/0166-2236(93)90117-5 Beal, 1986, Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid, Nature, 321, 168, 10.1038/321168a0 Beal, 1989, Differential sparing of somatostatin-neuropeptide Y and cholinergic neurons following striatal excitotoxin lesions, Synapse, 3, 38, 10.1002/syn.890030106 Beal, 1988, Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease, Ann. Neurol., 23, 562, 10.1002/ana.410230606 Beal, 1991, Aminooxyacetic acid results in excitotoxin lesions by a novel indirect mechanism, J. Neurochem., 57, 1068, 10.1111/j.1471-4159.1991.tb08258.x Bernard, 1997, Cellular, subcellular, and subsynaptic distribution of AMPA-type glutamate receptor subunits in the neostriatum of the rat, J. Neurosci., 17, 819, 10.1523/JNEUROSCI.17-02-00819.1997 Björklund, A., and T. Hökfelt. 1984. Classical transmitters in the CNS. In A. Björklund and T. Hökfelt, Eds., Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam. Borlongan, 1995, Systemic 3-nitropropionic acid: Behavioral deficits and striatal damage in adult rats, Brain Res. Bull., 36, 549, 10.1016/0361-9230(94)00242-S Brouillet, 1998, Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat, J. Neurochem., 70, 794, 10.1046/j.1471-4159.1998.70020794.x Brouillet, 1995, Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates, Proc. Natl. Acad. Sci. USA, 92, 7105, 10.1073/pnas.92.15.7105 Bruyn, 1986, Huntington's chorea. Historical, clinical and laboratory synopsis, 298 Buck, 1981, Reduction in basal ganglia and substantia nigra substance P levels in Huntington's disease, Brain Res., 209, 464, 10.1016/0006-8993(81)90171-2 Burke, 1996, Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH, Nat. Med., 2, 347, 10.1038/nm0396-347 Burke, 1993, Relative loss of the striatal striosome compartment, defined by calbindin-D28k immunostaining, following developmental hypoxic–ischemic injury, Neuroscience, 56, 305, 10.1016/0306-4522(93)90333-B Burke, 1990, Quantitative morphological analysis of striatal cholinergic neurons in perinatal asphyxia, Ann. Neurol., 27, 81, 10.1002/ana.410270113 Burke, 1991, The effect of neonatal hypoxia–ischemia on striatal cholinergic neuropil: A quantitative morphologic analysis, Exp. Neurol., 113, 63, 10.1016/0014-4886(91)90147-5 Celio, 1990, Calbindin D-28k and parvalbumin in the rat nervous system, Neuroscience, 35, 375, 10.1016/0306-4522(90)90091-H Celio, 1988, Monoclonal antibodies directed against the calcium binding protein parvalbumin, Cell Calcium, 9, 81, 10.1016/0143-4160(88)90027-9 Cha, 1998, Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene, Proc. Natl. Acad. Sci. USA, 95, 6480, 10.1073/pnas.95.11.6480 Chen, 1996, Cellular distribution of the NMDA receptor NR2A/2B subunits in the rat striatum, Brain Res., 743, 346, 10.1016/S0006-8993(96)01098-0 Chen, 1997, Evidence for the preferential localization of GluR1 subunits of AMPA receptors to the dentritic spines of medium spiny neurons in rat striatum, Neuroscience, 83, 715 Chesselet, 1990, Ischemic damage in the striatum of adult gerbils: Relative sparing of somatostatinergic and cholinergic interneurons contrasts with loss of efferent neurons, Exp. Neurol., 110, 209, 10.1016/0014-4886(90)90032-N Choi, 1990, The role of glutamate neurotoxicity in hypoxic–ischemic neuronal death, Annu. Rev. Neurosci., 13, 171, 10.1146/annurev.ne.13.030190.001131 Davies, 1987, No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acid, Nature, 327, 326, 10.1038/327326a0 Davies, 1988, Sparing of cholinergic neurons following quinolinic acid lesions of the rat striatum, Neuroscience, 26, 387, 10.1016/0306-4522(88)90156-X Davies, 1997, Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, 90, 537, 10.1016/S0092-8674(00)80513-9 DiFiglia, 1990, Excitotoxic injury of the neostriatum: A model for Huntington's disease, Trends Neurosci., 13, 286, 10.1016/0166-2236(90)90111-M Ferer, 1994, Parvalbumin-immunoreactive neurons in the cerebral cortex in Huntington's disease, Neurodegeneration, 3, 169 Ferrante, 1987, Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease, Brain Res., 411, 162, 10.1016/0006-8993(87)90694-9 Ferrante, 1985, Selective sparing of a class of striatal neurons in Huntington's disease, Science, 230, 561, 10.1126/science.2931802 Ferriero, 1988, Selective sparing of NADPH-diaphorase neurons in neonatal hypoxia–ischemia, Ann. Neurol., 24, 670, 10.1002/ana.410240512 Figueredo-Cardenas, 1994, Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats, Exp. Neurol., 129, 37, 10.1006/exnr.1994.1145 Figueredo-Cardenas, 1997, Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats, Exp. Neurol., 146, 444, 10.1006/exnr.1997.6549 Figueredo-Cardenas, 1998, Relative resistance of striatal neurons containing calbindin or parvalbumin to quinolinic acid-mediated excitotoxicity compared to other striatal neuron types, Exp. Neurol., 149, 356, 10.1006/exnr.1997.6724 Figueredo-Cardenas, 1996, Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats, Brain Res., 735, 317, 10.1016/0006-8993(96)00801-3 Fink-Jensen, 1989, The striato-entopeduncular pathway in the rat. A retrograde transport study with wheatgerm-agglutinin–horseradish peroxidase, Brain Res., 476, 194, 10.1016/0006-8993(89)91558-8 Forloni, 1992, Chronic infusion of quinolinic acid in rat striatum: Effects on discrete neuronal populations, J. Neurol. Sci., 108, 129, 10.1016/0022-510X(92)90043-K Fox, C. A., J. A. Rafols, and W. M. Cowan. 1975. Computer measurements of axis cylinder diameters of radial fibers and “comb” bundle fibers. 159: 201–223. Francis, 1982, The response of GABAergic and cholinergic neurons to transient cerebral ischemia, Brain Res., 243, 271, 10.1016/0006-8993(82)90250-5 Freund, 1990, Relationship of neuronal vulnerability and calcium binding protein immunoreactivity in ischemia, Exp. Brain Res., 83, 55, 10.1007/BF00232193 Fu, 1995, 3-Nitropropionic acid produces indirect excitotoxic damage to rat striatum, Neurotoxicol. Teratol., 17, 333, 10.1016/0892-0362(94)00076-P Fusco, 1999, Cellular localization of huntingtin in striatal and cortical neurons in rats: Lack of correlation with neuronal vulnerability in Huntington's disease, J. Neurosci., 19, 1189, 10.1523/JNEUROSCI.19-04-01189.1999 Gonzales, 1992, Relative sparing of GABAergic interneurons in the striatum of gerbils with ischemia-induced lesions, Neurosci. Lett., 135, 53, 10.1016/0304-3940(92)90134-S Grafton, 1992, Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington's disease, Arch. Neurol., 49, 1161, 10.1001/archneur.1992.00530350075022 Graybiel, 1990, Neurotransmitters and neuromodulators in the basal ganglia, Trends Neurosci., 13, 244, 10.1016/0166-2236(90)90104-I Greene, 1996, Inhibition of succinate dehydrogenase by malonic acid produces an “excitotoxic” lesion in rat striatum, J. Neurochem., 61, 1151, 10.1111/j.1471-4159.1993.tb03634.x Grofova, 1970, An experimental electron microscopic study on the striatonigral projection in the cat, Exp. Brain Res., 11, 249, 10.1007/BF01474385 Guyot, 1997, Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid, Neuroscience, 79, 45, 10.1016/S0306-4522(96)00602-1 Harrington, 1991, Paravalbumin immunoreactive neurons resist degeneration in Huntington's disease striatum, J. Neuropathol. Exp. Neurol., 50, 309 Ikonomidou, 1996, Neurodegenerative disorders: Clues from glutamate and energy metabolism, Crit. Rev. Neurobiol., 10, 239, 10.1615/CritRevNeurobiol.v10.i2.50 Isaacs, 1994, Mapping of the colocalization of calretinin and tyrosine hydroxylase in the rat substantia nigra and ventral tegmental area, Exp. Brain Res., 99, 34, 10.1007/BF00241410 Johnson, 1986, Monoclonal antibodies and polyvalent antiserum to chicken choline acetyltransferase, J. Neurochem., 46, 968, 10.1111/j.1471-4159.1986.tb13064.x Johnston, 1987, Effects of postnatal hypoxia–ischemia on cholinergic neurons in the developing rat forebrain: Choline acetyltransferase immunocytochemistry, Brain Res., 431, 41, 10.1016/0165-3806(87)90193-3 Kanazawa, 1979, Substance P: Decrease in substantia nigra and globus pallidus in Huntington's disease, Adv. Neurol., 23, 496 Kanazawa, 1985, Studies on neurotransmitter markers and striatal neuronal cell density in Huntington's disease and dentatorubropallidoluysian atrophy, J. Neurol. Sci., 70, 151, 10.1016/0022-510X(85)90084-X Kawaguchi, 1990, Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin, J. Neurosci., 10, 3421, 10.1523/JNEUROSCI.10-10-03421.1990 Kirk, 1982 Kita, 1988, Glutamate decarboxylase immunoreactive neurons in rat neostriatum: Their morphological types and populations, Brain Res., 447, 346, 10.1016/0006-8993(88)91138-9 Kita, 1990, Parvalbumin-immunoreactive neurons in the rat neostriatum: A light and electron microscopic study, Brain Res., 536, 1, 10.1016/0006-8993(90)90002-S Kohler, 1983, Comparison of ibotenate and kainate neurotoxicity in rat brain: A histological study, Neuroscience, 8, 819, 10.1016/0306-4522(83)90013-1 Kowall, 1987, Pattern of cell loss in Huntington's disease, Trends Neurosci., 10, 24, 10.1016/0166-2236(87)90120-2 Krammer, 1979, Is there a selectivity of neuronal degeneration induced by intrastriatal injection of kainic acid?, Brain Res., 177, 577, 10.1016/0006-8993(79)90476-1 Landwehrmeyer, 1995, NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum, J. Neurosci., 15, 5297, 10.1523/JNEUROSCI.15-07-05297.1995 Lapper, 1992, Input from the frontal cortex and the parafascicular nucleus to cholinergic interneurons in the dorsal striatum of the rat, Neuroscience, 51, 533, 10.1016/0306-4522(92)90293-B Lapper, 1992, Cortical input to parvalbumin-immunoreactive neurones in the putamen of the squirrel monkey, Brain Res., 580, 215, 10.1016/0006-8993(92)90947-8 Lasker, 1987, Saccades in Huntington's disease: Initiation defects and distractibility, Neurology, 37, 364, 10.1212/WNL.37.3.364 Levine, 1999, Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease, J. Neurosci. Res., 58, 515, 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F Lipton, 1994, Excitatory amino acids as a final common pathway for neurologic disorders, N. Engl. J. Med., 330, 613, 10.1056/NEJM199403033300907 Loopuijt, 1985, Organization of the striatum: Collateralization of its efferent axons, Brain Res., 348, 86, 10.1016/0006-8993(85)90363-4 Luo, 1999, Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-kappaB in rats, Mol. Pharmacol., 56, 254, 10.1124/mol.56.2.254 Mallard, 1995, Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain, Neuroscience, 65, 827, 10.1016/0306-4522(94)00504-X Mangiarini, 1996, Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice, Cell, 87, 493, 10.1016/S0092-8674(00)81369-0 Martin, 1984, Huntington's disease: New approaches to an old problem. The Robert Wartenberg lecture, Neurology, 34, 1059, 10.1212/WNL.34.8.1059 Martin, 1986, Huntington's disease. Pathogenesis and management, N. Engl. J. Med., 315, 1267, 10.1056/NEJM198611133152006 Martin, 1993, AMPA glutamate receptor subunits are differentially distributed in rat brain, Neuroscience, 53, 327, 10.1016/0306-4522(93)90199-P McWilliams, R., and G. Lynch. 1979. Terminal proliferation in the partially deafferented dentate gyrus: Time courses for the appearance and removal of degeneration and the replacement of lost terminals. 187: 191–198. Medina, 1996, Differential abundance of superoxide dismutase in interneurons versus projection neurons and in matrix versus striosome neurons in monkey striatum, Brain Res., 708, 59, 10.1016/0006-8993(95)01320-2 Novelli, 1988, Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced, Brain Res., 451, 205, 10.1016/0006-8993(88)90765-2 Palfi, 1996, Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease, J. Neurosci., 16, 3019, 10.1523/JNEUROSCI.16-09-03019.1996 Paschen, 1996, Glutamate excitotoxicity in transient global cerebral ischemia, Acta Neurobiol. Exp., 56, 313, 10.55782/ane-1996-1136 Paxinos, 1982 Pellegrini-Giampietro, 1990, Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage, J. Neurosci., 10, 1035, 10.1523/JNEUROSCI.10-03-01035.1990 Petralia, 1992, Light and electron immunocytochemical localization of AMPA-selective glutamate receptors in the rat brain, J. Comp. Neurol., 318, 329, 10.1002/cne.903180309 Poirier, 1983, Comparative morphology of the substantia nigra and ventral tegmental area in the monkey, cat and rat, Brain Res. Bull., 11, 371, 10.1016/0361-9230(83)90173-9 Pulsinelli, 1979, A new model of bilateral hemispheric ischemia in the unanesthetized rat, Stroke, 10, 267, 10.1161/01.STR.10.3.267 Pulsinelli, 1982, Temporal profile of neuronal damage in a model of transient forebrain ischemia, Ann. Neurol., 11, 491, 10.1002/ana.410110509 Qin, 1992, Effects of quinolinic acid on messenger RNAs encoding somatostatin and glutamic acid decarboxylases in the striatum of adult rats, Exp. Neurol., 115, 200, 10.1016/0014-4886(92)90054-T Rajakumar, 1993, Compartmental origin of the striato-entopeduncular projection in the rat, J. Comp. Neurol., 331, 286, 10.1002/cne.903310210 Reiner, 1987, The distribution of proenkephalin-derived peptides in the central nervous system of turtles, J. Comp. Neurol., 259, 65, 10.1002/cne.902590106 Reiner, 1994, Catecholaminergic innervation of the basal ganglia in mammals, 247 Reiner, 1988, Differential loss of striatal projection neurons in Huntington disease, Proc. Natl. Acad. Sci. USA, 85, 5733, 10.1073/pnas.85.15.5733 Reiner, 1990, The patterns of neurotransmitter and neuropeptide co-occurrence among striatal projection neurons: Conclusions based on recent findings, Brain Res. Brain Res. Rev., 15, 251, 10.1016/0165-0173(90)90003-7 Reynolds, 1990, Brain GABA levels in asymptomatic Huntington's disease, N. Engl. J. Med., 323, 682, 10.1056/NEJM199009063231013 Richfield, 1994, Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus, Ann. Neurol., 36, 577, 10.1002/ana.410360406 Richfield, 1995, Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients, Ann. Neurol., 38, 852, 10.1002/ana.410380605 Rushlow, 1995, Colocalization of somatostatin, neuropeptide Y, and NADPH-diaphorase in the caudate-putamen of the rat, J. Comp. Neurol., 351, 499, 10.1002/cne.903510403 Sancesario, 1996, Differential distribution of nicotinamide adenine dinucleotide phosphate-diaphorase and neural nitric oxide synthase in the rat choroid plexus. A histochemical and immunocytochemical study, Neuroscience, 72, 365, 10.1016/0306-4522(95)00538-2 Sapp, 1995, Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis, Neuroscience, 64, 397, 10.1016/0306-4522(94)00427-7 Sato, 1993, The differential expression patterns of messenger RNAs encoding non-N-methyl-d-aspartate glutamate receptor subunits (GluR1–4) in the rat brain, Neuroscience, 52, 515, 10.1016/0306-4522(93)90403-3 Schwarcz, 1983, Differential vulnerability of central neurons of the rat to quinolinic acid, Neurosci. Lett., 38, 85, 10.1016/0304-3940(83)90115-5 Seizinger, 1986, Opioid peptides in Huntington's disease: Alterations in prodynorphin and proenkephalin system, Brain Res., 378, 405, 10.1016/0006-8993(86)90946-7 Shoulson, 1984, Huntington's disease. A decade of progress, Neurol. Clin., 2, 515, 10.1016/S0733-8619(18)31088-0 Spokes, 1980, Neurochemical alterations in Huntington's chorea: A study of post-mortem brain tissue, Brain, 103, 179, 10.1093/brain/103.1.179 Starr, 1967, A disorder of rapid eye movements in Huntington's chorea, Brain, 90, 545, 10.1093/brain/90.3.545 Storey, 1993, Neurochemical substrates of rigidity and chorea in Huntington's disease, Brain, 116, 1201, 10.1093/brain/116.5.1201 Tallaksen-Greene, 1994, Localization of AMPA-selective excitatory amino acid receptor subunits in identified populations of striatal neurons, Neuroscience, 61, 509, 10.1016/0306-4522(94)90430-8 Tallaksen-Greene, 1996, Splice variants of glutamate receptor subunits 2 and 3 in striatal projection neurons, Neuroscience, 75, 1057, 10.1016/0306-4522(96)00337-5 Uemura, 1990, Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum, Ann. Neurol., 27, 620, 10.1002/ana.410270606 Vincent, 1983, NADPH-diaphorase: A selective histochemical marker for the cholinergic neurons of the pontine reticular formation, Neurosci. Lett., 43, 31, 10.1016/0304-3940(83)90124-6 Vis, 1999, 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum, Neuropathol. Appl. Neurobiol., 25, 513, 10.1046/j.1365-2990.1999.00212.x Waldvogel, 1991, Differential sensitivity of calbindin and parvalbumin immunoreactive cells in the striatum to excitotoxins, Brain Res., 546, 329, 10.1016/0006-8993(91)91497-O Wilson, 1987, Morphology and synaptic connections of crossed corticostriatal neurons in the rat, J. Comp. Neurol., 263, 567, 10.1002/cne.902630408 Young, 1988, NMDA receptor losses in putamen from patients with Huntington's disease, Science, 241, 981, 10.1126/science.2841762 Young, 1987, Normal caudate glucose metabolism in persons at risk for Huntington's disease, Arch. Neurol., 44, 254, 10.1001/archneur.1987.00520150010010 Young, 1986, Huntington's disease in Venezuela: Neurologic features and functional decline, Neurology, 36, 244, 10.1212/WNL.36.2.244